ReviewCurrent oncology (Toronto, Ont.)2014
Learning experiences with sunitinib continuous daily dosing in patients with pancreatic neuroendocrine tumours.
E Raymond et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it